The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Synergistic Antifungal Activities of Bafilomycin A 1 , Fluconazole, and the Pneumocandin MK-0991/Caspofungin Acetate (L-743,873) with Calcineurin Inhibitors FK506 and L-685,818 against Cryptococcus neoformans
Open accessAbstract
Cryptococcus neoformans is an opportunistic fungal pathogen that causes life-threatening infections of the central nervous system. Existing therapies include amphotericin B, fluconazole, and flucytosine, which are limited by toxic side effects and the emergence of drug resistance. We recently demonstrated that the protein phosphatase calcineurin is required for growth at 37 degrees C and virulence of C. neoformans. Because calcineurin is the target of potent inhibitors in widespread clinical use, cyclosporine and FK506 (tacrolimus), it is an attractive drug target for novel antifungal agents. Here we have explored the synergistic potential of combining the calcineurin inhibitor FK506 or its nonimmunosuppressive analog, L-685,818, with other antifungal agents and examined the molecular basis of FK506 action by using genetically engineered fungal strains that lack the FK506 target proteins FKBP12 and calcineurin. We demonstrate that FK506 exhibits marked synergistic activity with the H(+)ATPase inhibitor bafilomycin A(1) via a novel action distinct from calcineurin loss of function. FK506 also exhibits synergistic activity with the pneumocandin MK-0991/caspofungin acetate (formerly L-743,873), which targets the essential beta-1,3 glucan synthase, and in this case, FK506 action is mediated via FKBP12-dependent inhibition of calcineurin. Finally, we demonstrate that FK506 and fluconazole have synergistic activity that is independent of both FKBP12 and calcineurin and may involve the known ability of FK506 to inhibit multidrug resistance pumps, which are known to export azoles from fungal cells. In summary, our studies illustrate the potential for synergistic activity of a variety of different drug combinations and the power of molecular genetics to define the mechanisms of drug action, as well as identify a novel action of FK506 that could have profound implications for therapeutic or toxic effects in other organisms, including humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Calcineurin inhibitors also synergize with fluconazole against C. neoformans (Del Poeta et al. 2000)”
From Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence (2022) · cites this paper as Del Poeta et al. 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Bowman, E. J., Siebers, A., & Altendorf, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7972 · Cited by 1,801
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
Mitchell, T. G., & Perfect, J. R. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.515 · Cited by 1,213
Antifungal drug resistance of pathogenic fungi
Kontoyiannis, D. P., & Lewis, R. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08162-x · Cited by 553
Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases
Dröse, S., & Altendorf, K. (1997) · Journal of Experimental Biology · doi:10.1242/jeb.200.1.1 · Cited by 533
Calcineurin is required for virulence of Cryptococcus neoformans
Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J., & Heitman, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2576 · Cited by 516
Differential Expression and Function of Two Homologous Subunits of Yeast 1,3-β-D-Glucan Synthase
Mazur, P., Morin, N. R., Baginsky, W. F., El-Sherbeini, M., Clemas, J. A., NIELSEN, J. B. K., & Foor, F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5671 · Cited by 425
Douglas, C. M., Foor, F., Marrinan, J. A., Morin, N., Nielsen, J. B., Dahl, A. M., Mazur, P., Baginsky, W., Li, W., & el-Sherbeini, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12907 · Cited by 401
Douglas, C. M., D'Ippolito, J. A., Shei, G.-J., Meinz, M., Onishi, J. C., Marrinan, J. A., Li, W., Abruzzo, G. K., Flattery, A. M., Bartizal, K. F., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2471 · Cited by 344
Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice
Kwon-Chung, K. J., Polacheck, I., & Popkin, T. J. (1982) · Journal of Bacteriology · doi:10.1128/jb.150.3.1414-1421.1982 · Cited by 327
Antifungal drug resistance in pathogenic fungi.
BOSSCHE, H. V., Dromer, F., Improvisi, I., Lozano‐Chiu, M., Rex, J. H., & Sanglard, D. (1998) · PubMed · Cited by 290
Nakamura, T., Liu, Y., Hirata, D., Namba, H., Harada, S., Hirokawa, T., & Miyakawa, T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06090.x · Cited by 270
Sharom, F. J., Yu, X., Chu, J. W. K., & Doige, C. A. (1995) · Biochemical Journal · doi:10.1042/bj3080381 · Cited by 217
Zhao, C., Jung, U. S., Garrett-Engele, P., Roe, T., Cyert, M. S., & Levin, D. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1013 · Cited by 209
Thompson, J. R., Douglas, C. M., Li, W., Jue, C. K., Pramanik, B., Yuan, X., Rude, T. H., Toffaletti, D. L., Perfect, J. R., & Kurtz, M. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.2.444-453.1999 · Cited by 196
Garrett-Engele, P. W., Moilanen, B., & Cyert, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4103 · Cited by 187
The alpha-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene.
Moore, T. D. E., & Edman, J. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1962-1970.1993 · Cited by 178
Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans
Rhodes, J. C., Polacheck, I., & Kwon-Chung, K. J. (1982) · Infection and Immunity · doi:10.1128/iai.36.3.1175-1184.1982 · Cited by 175
Yoshida, T., Toda, T., & Yanagida, M. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.7.1725 · Cited by 169
Cruz, M. C., Cavallo, L. M., Görlach, J. M., Cox, G. M., Perfect, J. R., Cardenas, M. E., & Heitman, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4101 · Cited by 168
Poeta, M. D., Schell, W. A., & Perfect, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1835 · Cited by 165
Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.
Cardenas, M. E., Hemenway, C. S., Muir, R. S., Ye, R., Fiorentino, D. F., & Heitman, J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06940.x · Cited by 160
Egner, R., Rosenthal, F. E., Kralli, A., Sanglard, D., & Kuchler, K. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.2.523 · Cited by 153
John, A. R. O., Poeta, M. D., Perfect, J. R., & Heitman, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.156 · Cited by 153
Arceci, R. J., Stieglitz, K. A., & Bierer, B. E. (1992) · Blood · doi:10.1182/blood.v80.6.1528.1528 · Cited by 140
Kurtz, M., Abruzzo, G. K., Flattery, A. M., Bartizal, K. F., Marrinan, J. A., Li, W., Milligan, J. A., Nollstadt, K. H., & Douglas, C. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3244-3251.1996 · Cited by 136
Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains.
Breuder, T., Hemenway, C. S., Movva, N. R., Cardenas, M. E., & Heitman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5372 · Cited by 135
Ishiguro, J., Saitou, A., Durán, A., & Ribas, J. C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.24.7653-7662.1997 · Cited by 130
Cruz, M. C., Poeta, M. D., Wang, P., Wenger, R. M., Zenke, G., Quesniaux, V. F. J., Movva, N. R., Perfect, J. R., Cardenas, M. E., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.143-149.2000 · Cited by 129
Perfect, J. R., Toffaletti, D. L., & Rude, T. H. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4446-4451.1993 · Cited by 128
Prokisch, H., Yarden, O., Dieminger, M., Tropschug, M., & Barthelmess, I. B. (1997) · Molecular and General Genetics MGG · doi:10.1007/s004380050551 · Cited by 125
Franzot, S. P., & Casadevall, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.331 · Cited by 124
Vázquez, J. A., Lynch, M., Boikov, D. A., & Sobel, J. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1612 · Cited by 118
Rasmussen, C. D., Garen, C. R., Brining, S. K., Kincaid, R. L., Means, R. L., & Means, A. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06544.x · Cited by 115
Kinetic studies of chromaffin granule H+-ATPase and effects of bafilomycin A1
Hanada, H., Moriyama, Y., Maeda, M., & Futai, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92172-v · Cited by 111
Capsule size of Cryptococcus neoformans: control and relationship to virulence
Dykstra, M. A., Friedman, L., & Murphy, J. W. (1977) · Infection and Immunity · doi:10.1128/iai.16.1.129-135.1977 · Cited by 110
Fungal Plasma Membrane Proton Pumps as Promising New Antifungal Targets
Monk, B. C., & Perlin, D. S. (1994) · Critical Reviews in Microbiology · doi:10.3109/10408419409114555 · Cited by 88
Eng, W.-K., Faucette, L. F., McLaughlin, M. M., Cafferkey, R., Koltin, Y., Morris, R. A., Young, P. R., Johnson, R. K., & Livi, G. P. (1994) · Gene · doi:10.1016/0378-1119(94)90633-5 · Cited by 86
Withee, J. L., Sen, R., & Cyert, M. (1998) · Genetics · doi:10.1093/genetics/149.2.865 · Cited by 80
Maesaki, S., Marichal, P., Hossain, M., Sanglard, D., BOSSCHE, H. V., & KOHNO, S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.6.747 · Cited by 78
Cruz, M. C., Sia, R. A. L., Olson, M. E., Cox, G. M., & Heitman, J. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.982-985.2000 · Cited by 75
Calcineurin Subunit B Is Required for Normal Vegetative Growth inNeurospora crassa
Kothe, G. O., & Free, S. J. (1998) · Fungal Genetics and Biology · doi:10.1006/fgbi.1998.1037 · Cited by 68
Hemenway, C. S., Dolinski, K. J., Cardenas, M. E., Hiller, M. A., Jones, E. W., & Heitman, J. (1995) · Genetics · doi:10.1093/genetics/141.3.833 · Cited by 62
Reversal of multidrug resistance by an immunosuppressive agent FK-506
Naito, M., Oh‐hara, T., Yamazaki, A., Danki, T., & Tsuruo, T. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686252 · Cited by 62
Raymond, M., Ruetz, S., Thomas, D. Y., & Gros, P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.277 · Cited by 62
The Plasma Membrane H+‐ATPase of Fungi
Perlin, D. S., Seto‐Young, D., & Monk, B. C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52330.x · Cited by 60
Effects of cyclosporine in experimental cryptococcal meningitis
Perfect, J. R., & Durack, D. T. (1985) · Infection and Immunity · doi:10.1128/iai.50.1.22-26.1985 · Cited by 54
Nelson, P. W., Lozano‐Chiu, M., & Rex, J. H. (1997) · Medical Mycology · doi:10.1080/02681219780001291 · Cited by 52
Characterization of yeast plasma membrane H(+)-ATPase mutant pma1-A135V and its revertants
Na, S., Perlin, D. S., Seto‐Young, D., Wang, G., & Haber, J. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50269-1 · Cited by 42
Hunke, S., Drose, S., & Schneider, E. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2663 · Cited by 40
Mizuno, K., Furuhashi, Y., Misawa, T., Iwata, M., Kawai, M., Kikkawa, F., Kano, T., & Tomoda, Y. (1992) · PubMed · Cited by 32
Monk, B. C., Feng, W. C., Marshall, C. J., Seto‐Young, D., Na, S., Haber, J. E., & Perlin, D. S. (1994) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00763222 · Cited by 25
Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives
Jachez, B., Boesch, D., Grassberger, M. A., & Loor, F. (1993) · Anti-Cancer Drugs · doi:10.1097/00001813-199304000-00015 · Cited by 16
Raymond, M., Ruetz, S., Thomas, D. Y., & Gros, P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.277-286.1994 · Cited by 11
Research works printed but not linked: 1
- Cox G. M. Perfect J. R. Fungal infections. Curr. Opin. Infect. Dis. 6 1993 422 426
Cited by
Sorted by citations
The Fungal Cell Wall: Structure, Biosynthesis, and Function
Gow, N. A. R., Latge, J.-P., & Munro, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0035-2016 · Cited by 1,423
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Signal Transduction Cascades Regulating Fungal Development and Virulence
Lengeler, K. B., Davidson, R. C., D'souza, C., Harashima, T., Shen, W.-C., Wang, P., Pan, X., Waugh, M., & Heitman, J. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.746-785.2000 · Cited by 915
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Combination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541
Metadata
- Authors
- Del Poeta, M., Cruz, M. C., Cardenas, M. E., Perfect, J. R., & Heitman, J.
- Affiliations
- <!--label omitted: 1-->Departments of Medicine,1
- <!--label omitted: 4-->Genetics,4
- Howard Hughes Medical Institute (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-03
- Volume
- 44
- Issue
- 3
- Pages
- 739-746
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC89756
- OpenAlex
- W2130655869
- Cited by
- 169
- References
- 55
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 2 · 2017: 13 · 2016: 6 · 2015: 4 · 2014: 11 · 2013: 7 · 2012: 6
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ai041937-03)
- National Institute of Allergy and Infectious Diseases (AI41937-01S1, P01AI044975, AI-44975, AI41937)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Cryptococcus neoformans, calcineurin, FK506, bafilomycin A1, fluconazole, caspofungin acetate, drug synergy, combination antifungal therapy, FKBP12, H+-ATPase inhibition, beta-1,3-glucan synthase, multidrug resistance pumps, opportunistic fungal infection
- MeSH terms
- Caspofungin, Anti-Bacterial Agents, Antifungal Agents, Cryptococcus neoformans, Drug Combinations, Drug Synergism, Humans, Microbial Sensitivity Tests, Peptides, Peptides, Cyclic, Fluconazole, Tacrolimus, Macrolides, Calcineurin, Immunophilins, Tacrolimus Binding Proteins, Echinocandins, Lipopeptides, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review